ZAI LAB LIMITED Inventory Write-down
ZAI LAB LIMITED (ZLAB) reported Inventory Write-down of $6.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-06
- ZAI LAB LIMITED inventory write-down for the quarter ending 2026-06-30 was $5.89M, a 2107.49% increase year-over-year.
- ZAI LAB LIMITED inventory write-down for the quarter ending 2026-03-31 was $188.00K, a 596.30% increase year-over-year.
- ZAI LAB LIMITED inventory write-down for the quarter ending 2025-12-31 was $11.37M, a 1136800.00% increase year-over-year.
- ZAI LAB LIMITED inventory write-down for the quarter ending 2025-09-30 was $625.00K, a 977.59% increase year-over-year.
- ZAI LAB LIMITED inventory write-down for fiscal 2025 was $12.29M, a 1407.73% increase from fiscal 2024.
- ZAI LAB LIMITED inventory write-down for fiscal 2024 was $815.00K, a 16.24% decline from fiscal 2023.
- ZAI LAB LIMITED inventory write-down for fiscal 2023 was $973.00K, a 103.98% increase from fiscal 2022.
- ZAI LAB LIMITED inventory write-down for fiscal 2022 was $477.00K, a 65.13% decline from fiscal 2021.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.08M 10-Q · filed 2026-08-06 | $17.45M derived: sum of 3 quarters · filed 2026-08-06 | $18.08M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $188.00K 10-Q · filed 2026-05-07 | $11.56M derived: sum of 2 quarters · filed 2026-05-07 | $12.18M derived: sum of 3 quarters · filed 2026-05-07 | $12.45M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $11.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.99M derived: sum of 2 quarters · filed 2026-02-26 | $12.26M derived: sum of 3 quarters · filed 2026-08-06 | $12.29M 10-K · filed 2026-02-26 |
| 2025-09-30 | $625.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $892.00K derived: sum of 2 quarters · filed 2026-08-06 | $919.00K 10-Q · filed 2025-11-06 | $920.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $267.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $294.00K 10-Q · filed 2026-08-06 | $295.00K derived: sum of 3 quarters · filed 2026-08-06 | $353.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $27.00K 10-Q · filed 2026-05-07 | $28.00K derived: sum of 2 quarters · filed 2026-05-07 | $86.00K derived: sum of 3 quarters · filed 2026-05-07 | $805.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $59.00K derived: sum of 2 quarters · filed 2026-02-26 | $778.00K derived: sum of 3 quarters · filed 2026-02-26 | $815.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $777.00K derived: sum of 2 quarters · filed 2025-11-06 | $814.00K 10-Q · filed 2025-11-06 | $1.04M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $719.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $756.00K 10-Q · filed 2025-08-07 | $983.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.11M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $37.00K 10-Q · filed 2025-05-08 | $264.00K derived: sum of 2 quarters · filed 2026-02-26 | $387.00K derived: sum of 3 quarters · filed 2026-02-26 | $633.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $350.00K derived: sum of 2 quarters · filed 2026-02-26 | $596.00K derived: sum of 3 quarters · filed 2026-02-26 | $973.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $369.00K derived: sum of 2 quarters · filed 2024-11-12 | $746.00K 10-Q · filed 2024-11-12 | $743.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $246.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $623.00K 10-Q · filed 2024-08-06 | $620.00K derived: sum of 3 quarters · filed 2025-02-27 | $907.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $377.00K 10-Q · filed 2024-05-08 | $374.00K derived: sum of 2 quarters · filed 2025-02-27 | $661.00K derived: sum of 3 quarters · filed 2025-02-27 | $716.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $284.00K derived: sum of 2 quarters · filed 2025-02-27 | $339.00K derived: sum of 3 quarters · filed 2025-02-27 | $477.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $287.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $342.00K derived: sum of 2 quarters · filed 2023-11-07 | $480.00K 10-Q · filed 2023-11-07 | $1.45M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $193.00K 10-Q · filed 2023-08-07 | $1.16M derived: sum of 3 quarters · filed 2024-02-27 | $1.27M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $138.00K 10-Q · filed 2023-05-09 | $1.10M derived: sum of 2 quarters · filed 2024-02-27 | $1.22M derived: sum of 3 quarters · filed 2024-02-27 | $1.49M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $966.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.08M derived: sum of 2 quarters · filed 2024-02-27 | $1.35M derived: sum of 3 quarters · filed 2024-02-27 | $1.37M 10-K · filed 2024-02-27 |
| 2021-09-30 | $112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $388.00K derived: sum of 2 quarters · filed 2022-11-09 | $402.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $276.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $290.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $14.00K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $29.00K 10-K · filed 2023-03-01 | |||
| 2020-06-30 | $7.00K 10-Q · filed 2021-08-09 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 6-K 9 month · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $0.00 6-K · filed 2020-01-21 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |